Amgen | AMGN - Passifs Courants





Passifs Courants Changement Date
AbbVie USD 43.1B 1.46B 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Eli Lilly USD 47B 745M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Genmab DKK 1.14B 38M 2026-06
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Glaxosmithkline GBP 20.72B 1.71B 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 55.46B 562M 2026-09
Merck USD 28.8B 1.07B 2026-09
Moderna USD 2.53B 139M 2026-06
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Takeda JPY 2.6T 161B 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09